Peter Altman - May 11, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: President and CEO, Director
Signature: /s/ David McClung, by power of attorney
Stock symbol: BCDA
Transactions as of: May 11, 2022
Transactions value $: $18,586
Form type: 4
Date filed: 5/13/2022, 06:32 PM
Previous filing: May 2, 2022
Next filing: Apr 7, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Purchase	$1.3K	+1K	+0.3%	$1.30	334K	May 11, 2022	Direct	F1
transaction	BCDA	Common Stock	Purchase	$13.6K	+11.3K	+3.38%	$1.20	345K	May 12, 2022	Direct	F2
transaction	BCDA	Common Stock	Purchase	$3.72K	+2.7K	+0.78%	$1.38	348K	May 13, 2022	Direct	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades ranging from $1.29 to $1.30 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2	This transaction was executed in multiple trades ranging from $1.13 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3	This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.